Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal. 2014

Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.

Recent reports suggest that brain-derived neurotrophic factor (BDNF) could be a biomarker for relapse, drug craving and withdrawal severity. In particular, elevated BDNF levels among former cocaine users have been associated with higher rates of relapse in 90 d. However, no data are available on BDNF levels at baseline and during crack cocaine withdrawal. This study evaluated BDNF among crack cocaine users during inpatient treatment, before and after withdrawal, vs. healthy controls. Clinical correlates with changes in BDNF levels were also assessed. Serum BDNF was evaluated in 49 male crack users on the first and last days of hospitalization and in 97 healthy controls. Serum BDNF was assayed using a sandwich ELISA kit. BDNF levels were significantly lower upon admission when compared to controls, even after adjustment for age, length of inpatient treatment, number of crack rocks used in the last 30 d, years of crack use and interaction between the latter two variables. At discharge, BDNF levels between patients and controls were similar. Number of crack rocks used in the last 30 d and years of crack use were inversely correlated with the outcome. Our findings show that BDNF levels increase during early crack cocaine withdrawal, at an inverse correlation with number of crack rocks used in the last 30 d and years of crack use.

UI MeSH Term Description Entries
D008297 Male Males
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016578 Crack Cocaine The purified, alkaloidal, extra-potent form of cocaine. It is smoked (free-based), injected intravenously, and orally ingested. Use of crack results in alterations in function of the cardiovascular system, the autonomic nervous system, the central nervous system, and the gastrointestinal system. The slang term "crack" was derived from the crackling sound made upon igniting of this form of cocaine for smoking. Cocaine, Crack
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D019208 Brain-Derived Neurotrophic Factor A member of the nerve growth factor family of trophic factors. In the brain BDNF has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. (From Kendrew, The Encyclopedia of Molecular Biology, 1994) BDNF,Brain Derived Neurotrophic Factor,Factor, Brain-Derived Neurotrophic,Neurotrophic Factor, Brain-Derived

Related Publications

Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
January 2015, European addiction research,
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
February 2010, Brain research,
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
January 2024, Substance abuse treatment, prevention, and policy,
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
January 2008, Alcohol and alcoholism (Oxford, Oxfordshire),
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
May 2014, Addiction biology,
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
October 2017, Neurotoxicity research,
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
September 2013, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
June 2014, Journal of psychiatric research,
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
June 2014, Neuroscience letters,
Lisia von Diemen, and Flavio Kapczinski, and Anne Orgle Sordi, and Joana Correa de Magalhães Narvaez, and Luciano Santos Pinto Guimarães, and Felix Henrique Paim Kessler, and Bianca Pfaffenseller, and Bianca Wollenhaupt de Aguiar, and Carolina de Moura Gubert, and Flavio Pechansky
October 2017, Journal of affective disorders,
Copied contents to your clipboard!